TipRanks
Go Ultimate55% OFF

Shield Therapeutics (STX) Cash flow

Shield Therapeutics Cash Flow

GB:STX's free cash flow for Q2 2026 was $712.11K. For the 2026 fiscal year, GB:STX's free cash flow was decreased by $-27.77K and operating cash flow was $739.89K. See a summary of the company’s cash flow.

Cash Flow
Cash FlowMar 26Dec 24Dec 23Dec 22Jun 22
$ -8.81M$ -8.77M$ -46.93M$ -18.25M$ -16.74M
$ -306.29K$ -2.37M$ -3.07M$ -1.70M$ -2.05M
$ 13.75M$ 5.26M$ 62.77M$ 7.71M$ 27.58M
$ 11.63M$ 7.02M$ 17.63M$ 2.82M$ 12.12M
$ -8.83M$ -8.80M$ -50.65M$ -20.14M$ -18.80M

Currency in USD

Shield Therapeutics Cash Flow

-75M-50M-25M025M50M75M201720182019202020212022202320242025OperatingInvestingFinancing